Is this the sort of deal Michelle might chase? Thinking more along the HIV front for outside interest in BIT225.
Johnson & Johnson ($JNJ) has deepened its ties to regenerative medicine outfit ViaCyte, handing the biotech $20 million in exchange for a future stake in the company and the right to acquire its in-development diabetes medication. Under the deal, J&J's cash buys it a note convertible into equity and an exclusive chance to acquire VC-01, ViaCyte's stem cell-derived treatment for Type 1 diabetes.
- Forums
- ASX - By Stock
- cash up front or take over is very near
Is this the sort of deal Michelle might chase? Thinking more...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.48M |
Open | High | Low | Value | Volume |
3.6¢ | 3.6¢ | 3.6¢ | $20.79K | 577.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 76422 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 123461 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26832 | 0.036 |
2 | 279088 | 0.033 |
1 | 31250 | 0.032 |
1 | 90000 | 0.031 |
3 | 220000 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 121980 | 3 |
0.040 | 927370 | 1 |
0.041 | 44000 | 1 |
0.042 | 117600 | 1 |
0.043 | 200000 | 1 |
Last trade - 10.01am 27/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |